Leukemic cells (PBMC 94–99% ROR1+ cells) from patients with non-progressive or progressive CLL (as defined by IWCLL criteria), as well as of patients with fludarabine resistant disease with or without del(17p) were analyzed for KAN0439834 induced cytotoxicity. Here, ROR1 is linked to B-cell chronic lymphocytic leukemia.